Back to STIFEL FINANCIAL CORP STIFEL FINANCIAL CORP

TAKTAK
29 quarters

Position history for STIFEL FINANCIAL CORPSTIFEL FINANCIAL CORP's holdings in TAKEDA PHARMACEUTICAL CO LTD

STIFEL FINANCIAL CORP holds 628,550 shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), worth $11.6M as of 2026-Q1. The position was increased (+13.4% shares). TAK represents 0.0% of STIFEL FINANCIAL CORP's portfolio.

Current Value

$11.6M

Current Shares

628,550

Total Value Change

+$7.5M

Total Shares Change

+427,032

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
628,550
+13.4%
$11.6M0.0%$18.08
32
2025-Q4
Increased
554,290
+8.9%
$8.6M0.0%$15.63
30
2025-Q3
Increased
508,924
+12.1%
$7.5M0.0%$14.62
31
2025-Q2
Increased
454,019
+13.0%
$7M0.0%$15.10
31
2025-Q1
Decreased
401,782
-7.7%
$6M0.0%$14.71
0
2024-Q4
Decreased
435,141
-1.3%
$5.8M0.0%$12.87
0
2024-Q3
Increased
440,666
+103.9%
$6.3M0.0%$13.89
44
2024-Q2
Decreased
216,072
-26.6%
$2.8M0.0%$12.36
0
2024-Q1
Increased
294,215
+41.1%
$4.1M0.0%$13.27
36
2023-Q4
Decreased
208,443
-29.1%
$3M0.0%$13.36
0
2023-Q3
Increased
293,813
+5.3%
$4.5M0.0%$14.48
28
2023-Q2
Increased
279,047
+1.4%
$4.4M0.0%$14.70
27
2023-Q1
Increased
275,188
+142.9%
$4.5M0.0%$15.31
43
2022-Q4
Decreased
113,269
-8.4%
$1.8M0.0%$14.60
0
2022-Q3
Increased
123,697
+14.0%
$1.6M0.0%$12.14
29
2022-Q2
Increased
108,515
+13.2%
$1.5M0.0%$12.97
29
2022-Q1
Increased
95,836
+10.2%
$1.4M0.0%$13.51
28
2021-Q4
Increased
86,952
+13.3%
$1.2M0.0%$12.71
29
2021-Q3
Increased
76,740
+18.9%
$1.3M0.0%$15.27
30
2021-Q2
Increased
64,562
+0.6%
$1.1M0.0%$15.76
25
2021-Q1
Decreased
64,179
-59.2%
$1.2M0.0%$17.18
0
2020-Q4
Decreased
157,304
-21.5%
$2.9M0.0%$17.02
0
2020-Q3
Decreased
200,489
-2.0%
$3.6M0.0%$16.98
0
2020-Q2
Decreased
204,606
-6.4%
$3.7M0.0%$16.95
0
2020-Q1
Increased
218,665
+1.3%
$3.3M0.0%$14.63
27
2019-Q4
Increased
215,814
+13.5%
$4.3M0.0%$18.41
30
2019-Q3
Decreased
190,165
-8.6%
$3.3M0.0%$16.23
0
2019-Q2
Increased
208,056
+3.2%
$3.7M0.0%$16.57
27
2019-Q1
New
201,518
-
$4.1M0.0%$19.07
37

Other major holders of TAK: GLENVIEW CAPITAL MANAGEMENT, LLC, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used